利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

19 条记录 (耗时 0.041 秒)

    Pseudo wire label reflector, an edge equipment, and a two-layer virtual network
    3.
    发明授权
    Pseudo wire label reflector, an edge equipment, and a two-layer virtual network 有权
    伪线标签反射器，边缘设备和双层虚拟网络

    公开(公告)号：US08553694B2

    公开(公告)日：2013-10-08

    申请号：US12854584

    申请日：2010-08-11

    申请人： Ke Du ,  Mingyi Wang ,  Chunhong Huang ,  Jun Feng ,  Weidong Zhong

    发明人： Ke Du ,  Mingyi Wang ,  Chunhong Huang ,  Jun Feng ,  Weidong Zhong

    IPC分类号： H04L12/56

    CPC分类号： H04L12/4641 ,  H04L45/507

    摘要： A pseudo wire label reflector, based on a existing label distribution router, further includes: a mode management unit, for determining the mode for switching and transferring a pseudo wire label message; a first session management unit, for saving the support information that LDP signaling session connection supports the pseudo wire label reflecting capacity; a first pseudo wire label receiving unit, for receiving a pseudo wire label message; a first pseudo wire management unit, for saving the switched pseudo wire state and deciding whether to modify the pseudo wire label message according to the switch and transfer mode determined by the mode management unit; a first pseudo wire label sending unit, for sending the pseudo wire label message. The invention also provides an edge apparatus and a L2 VPN. The present invention makes PE equipments participating pseudo wire service to set up PSN tunnel and LDP signaling session connection with the pseudo wire label reflector by introducing the pseudo wire label reflector and extending the capacity that the current edge apparatus supports the pseudo wire label reflector.

    摘要翻译： 基于现有标签分发路由器的伪线标签反射器还包括：模式管理单元，用于确定用于切换和传送伪线标签消息的模式; 第一会话管理单元，用于保存LDP信令会话连接支持伪线标签反映能力的支持信息; 第一伪线标签接收单元，用于接收伪线标签消息; 第一伪线管理单元，用于保存切换伪线状态，并根据由模式管理单元确定的切换和传送模式来决定是否修改伪线标签消息; 第一伪线标签发送单元，用于发送伪线标签消息。 本发明还提供边缘设备和L2 VPN。 本发明使PE设备参与伪线业务，通过引入伪线标签反射器并扩展当前边缘设备支持伪线标签反射器的容量，建立伪线标签反射器的PSN隧道和LDP信令会话连接。

    HCV replicase complexes
    4.
    发明授权
    HCV replicase complexes 失效
    HCV复制酶复合物

    公开(公告)号：US06967075B2

    公开(公告)日：2005-11-22

    申请号：US09828034

    申请日：2001-04-06

    申请人： Weidong Zhong ,  Zhi Hong ,  Eric Ferrari

    发明人： Weidong Zhong ,  Zhi Hong ,  Eric Ferrari

    IPC分类号： C12N9/12 ,  C12Q1/70

    CPC分类号： C12N9/127 ,  C12Q1/707

    摘要： This invention provides efficient HCV replicase complexes comprising novel RNA template and primer pair. Assay systems are also provided, which use such complexes, for detecting replicase activity, quantitatively studying the kinetics and mechanism of HCV NS5B-catalyzed nucleotide incorporation, and identifying inhibitors of HCV replicase. The assay systems use small and well-defined synthetic RNAs which allow efficient assembly of all catalytic components in the quaternary complex for HCV NS5B-directed RNA replication. Specific template-primer requirements for efficient RNA synthesis by HCV NS5B replicase are provided for use in assay systems.

    摘要翻译： 本发明提供了包含新型RNA模板和引物对的有效的HCV复制酶复合物。 还提供了使用这种复合物的检测系统，用于检测复制酶活性，定量研究HCV NS5B催化的核苷酸掺入的动力学和机制，以及鉴定HCV复制酶的抑制剂。 测定系统使用小而且明确定义的合成RNA，其允许有效组装用于HCV NS5B定向RNA复制的季复合物中的所有催化组分。 提供HCV NS5B复制酶高效RNA合成的具体模板引物要求，用于测定系统。

    Pseudo Wire Label Reflector, an Edge Equipment, a Two-Layer Virtual Network and a Method of Providing Pseudo Wire Service
    6.
    发明申请
    Pseudo Wire Label Reflector, an Edge Equipment, a Two-Layer Virtual Network and a Method of Providing Pseudo Wire Service 有权
    伪线标签反射器，边缘设备，双层虚拟网络和提供伪线服务的方法

    公开(公告)号：US20080291921A1

    公开(公告)日：2008-11-27

    申请号：US11632445

    申请日：2005-01-04

    申请人： Ke Du ,  Mingyi Wang ,  Chunhong Huang ,  Jun Feng ,  Weidong Zhong

    发明人： Ke Du ,  Mingyi Wang ,  Chunhong Huang ,  Jun Feng ,  Weidong Zhong

    IPC分类号： H04L12/56

    CPC分类号： H04L12/4641 ,  H04L45/507

    摘要： A pseudo wire label reflector, based on a existing label distribution router, further includes: a mode management unit, for determining the mode for switching and transferring a pseudo wire label message; a first session management unit, for saving the support information that LDP signaling session connection supports the pseudo wire label reflecting capacity; a first pseudo wire label receiving unit, for receiving a pseudo wire label message; a first pseudo wire management unit, for saving the switched pseudo wire state and deciding whether to modify the pseudo wire label message according to the switch and transfer mode determined by the mode management unit; a first pseudo wire label sending unit, for sending the pseudo wire label message. The invention also provides an edge apparatus, a L2 VPN and a method for providing pseudo wire service in PSN. The present invention makes PE equipments participating pseudo wire service to set up PSN tunnel and LDP signaling session connection with the pseudo wire label reflector by introducing the pseudo wire label reflector and extending the capacity that the current edge apparatus supports the pseudo wire label reflector.

    摘要翻译： 基于现有标签分发路由器的伪线标签反射器还包括：模式管理单元，用于确定用于切换和传送伪线标签消息的模式; 第一会话管理单元，用于保存LDP信令会话连接支持伪线标签反映能力的支持信息; 第一伪线标签接收单元，用于接收伪线标签消息; 第一伪线管理单元，用于保存切换伪线状态，并根据由模式管理单元确定的切换和传送模式来决定是否修改伪线标签消息; 第一伪线标签发送单元，用于发送伪线标签消息。 本发明还提供一种边缘设备，L2 VPN和在PSN中提供伪线服务的方法。 本发明使PE设备参与伪线业务，通过引入伪线标签反射器并扩展当前边缘设备支持伪线标签反射器的容量，建立伪线标签反射器的PSN隧道和LDP信令会话连接。

    Viral specific requirements for self-priming RNA replication of hepatitis C virus replicase
    7.
    发明授权
    Viral specific requirements for self-priming RNA replication of hepatitis C virus replicase 失效
    丙型肝炎病毒复制酶自我启动RNA复制的病毒特异性要求

    公开(公告)号：US06322966B1

    公开(公告)日：2001-11-27

    申请号：US09309670

    申请日：1999-05-11

    申请人： Weidong Zhong ,  Zhi Hong ,  Johnson Y. N. Lau

    发明人： Weidong Zhong ,  Zhi Hong ,  Johnson Y. N. Lau

    IPC分类号： C12Q170

    CPC分类号： C12Q1/6867

    摘要： The present invention relates to identification of the features of an RNA template that provide for efficient “copy-back” self-priming activity of hepatitis C virus replicase. This activity can be used to screen for anti-HCV replicase compounds, or to characterize the biological relevance of lead compounds that have already been identified. The specific features of the optimal RNA templates can be used for developing a system to characterize HCV NS5B polymerase mechanistically and kinetically, and for designing small RNA molecules to co-crystallize with HCV NS5B polymerase.

    摘要翻译： 本发明涉及确定提供丙型肝炎病毒复制酶的有效“复制”自吸活性的RNA模板的特征。 该活性可用于筛选抗HCV复制酶化合物，或表征已鉴定的铅化合物的生物相关性。 最佳RNA模板的具体特征可用于开发系统，以机械和动力学表征HCV NS5B聚合体，并设计小RNA分子与HCV NS5B聚合酶共结晶。

    PSEUDO WIRE LABEL REFLECTOR, AN EDGE EQUIPMENT, AND A TWO-LAYER VIRTUAL NETWORK
    9.
    发明申请
    PSEUDO WIRE LABEL REFLECTOR, AN EDGE EQUIPMENT, AND A TWO-LAYER VIRTUAL NETWORK 有权
    PSEUDO线标签反射器，边缘设备和两层虚拟网络

    公开(公告)号：US20110026530A1

    公开(公告)日：2011-02-03

    申请号：US12854584

    申请日：2010-08-11

    申请人： Ke Du ,  Mingyi Wang ,  Chunhong Huang ,  Jun Feng ,  Weidong Zhong

    发明人： Ke Du ,  Mingyi Wang ,  Chunhong Huang ,  Jun Feng ,  Weidong Zhong

    IPC分类号： H04L12/28

    CPC分类号： H04L12/4641 ,  H04L45/507

    摘要： A pseudo wire label reflector, based on a existing label distribution router, further includes: a mode management unit, for determining the mode for switching and transferring a pseudo wire label message; a first session management unit, for saving the support information that LDP signaling session connection supports the pseudo wire label reflecting capacity; a first pseudo wire label receiving unit, for receiving a pseudo wire label message; a first pseudo wire management unit, for saving the switched pseudo wire state and deciding whether to modify the pseudo wire label message according to the switch and transfer mode determined by the mode management unit; a first pseudo wire label sending unit, for sending the pseudo wire label message. The invention also provides an edge apparatus and a L2 VPN. The present invention makes PE equipments participating pseudo wire service to set up PSN tunnel and LDP signaling session connection with the pseudo wire label reflector by introducing the pseudo wire label reflector and extending the capacity that the current edge apparatus supports the pseudo wire label reflector.

    摘要翻译： 基于现有标签分发路由器的伪线标签反射器还包括：模式管理单元，用于确定用于切换和传送伪线标签消息的模式; 第一会话管理单元，用于保存LDP信令会话连接支持伪线标签反映能力的支持信息; 第一伪线标签接收单元，用于接收伪线标签消息; 第一伪线管理单元，用于保存切换伪线状态，并根据由模式管理单元确定的切换和传送模式来决定是否修改伪线标签消息; 第一伪线标签发送单元，用于发送伪线标签消息。 本发明还提供边缘设备和L2 VPN。 本发明使PE设备参与伪线业务，通过引入伪线标签反射器并扩展当前边缘设备支持伪线标签反射器的容量，建立伪线标签反射器的PSN隧道和LDP信令会话连接。

    Cycloalkl, aryl and heteroaryl amino isothiazoles for the treatment of Hepatitis C virus
    10.
    发明申请
    Cycloalkl, aryl and heteroaryl amino isothiazoles for the treatment of Hepatitis C virus 审中-公开
    环烷基，芳基和杂芳基氨基异噻唑，用于治疗丙型肝炎病毒

    公开(公告)号：US20060217390A1

    公开(公告)日：2006-09-28

    申请号：US11361581

    申请日：2006-02-24

    申请人： Esmir Gunic ,  Todd Appleby ,  Weidong Zhong ,  Shunqi Yan ,  Ching Lai

    发明人： Esmir Gunic ,  Todd Appleby ,  Weidong Zhong ,  Shunqi Yan ,  Ching Lai

    IPC分类号： A61K31/506 ,  A61K31/501 ,  A61K31/497 ,  A61K31/4545 ,  A61K31/4439 ,  C07D417/14

    CPC分类号： C07D275/03 ,  C07D417/12 ,  C07D417/14

    摘要： This invention concerns certain 5-(substituted amino) isothiazoles, compounds of Formula I, and salts thereof, where Q is CN, NHCONRaRb, or CONRaRb, where Ra and Rb are defined herein; and R1 is cyclohexyl, adamantan-1-yl, indan-1-yl, phenyl, benzyl, pyridyl, pyridylmethyl, or pyrimidyl, where all aromatic R1 groups are optionally substituted, provided that when R1 is phenyl, then R1 bears at least one non-alkyl substituent, and further provided that R1 is not 4-chloro-3-trichloromethyl-phenyl; The invention also concerns the tautomeric 5-(substituted amino)-isothiazol-3(2H)-ones, and the use of such compounds to treat Hepatitis C infection. It also concerns thiocarbamoyl acetamides, which are synthetic precursors to the isothiazoles.

    摘要翻译： 本发明涉及某些5-（取代氨基）异噻唑，式I化合物及其盐，其中Q为CN，NHCONR a R b B或CONR 其中R a a和R bb在本文中定义;其中R a，R b和R b都定义如上。 和R 1是环己基，金刚烷-1-基，茚满-1-基，苯基，苄基，吡啶基，吡啶基甲基或嘧啶基，其中所有芳族R 1〜 任选地被取代，条件是当R 1为苯基时，R 1至少具有一个非烷基取代基，并且进一步地，R 1' 不是4-氯-3-三氯甲基 - 苯基; 本发明还涉及互变异构5-（取代氨基） - 异噻唑-3（2H） - 酮，以及这些化合物用于治疗丙型肝炎感染的用途。 它还涉及硫代氨基甲酰基乙酰胺，它们是异噻唑的合成前体。